Logo image of XFOR

X4 PHARMACEUTICALS INC (XFOR) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:XFOR - US98420X2027 - Common Stock

4.2 USD
-0.1 (-2.33%)
Last: 12/30/2025, 2:21:05 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
XFOR revenue by date.XFOR revenue by date.
2.557M35.201M
1,276.65%
13.782M
-60.85%
31.495M
128.52%
116.09M
268.60%
227.78M
96.21%
479.39M
110.46%
350.39M
-26.91%
622.58M
77.68%
EBITDA
YoY % growth
XFOR ebitda by date.XFOR ebitda by date.
-87.57M
-16.99%
-107.103M
-22.31%
-140.605M
-31.28%
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
XFOR ebit by date.XFOR ebit by date.
-88.08M
-16.89%
-107.522M
-22.07%
-141.401M
-31.51%
-87.609M
38.04%
-102.675M
-17.20%
-110.151M
-7.28%
-41.756M
62.09%
37.243M
189.19%
210.23M
464.48%
199.28M
-5.21%
336.02M
68.62%
Operating Margin
XFOR operating margin by date.XFOR operating margin by date.
N/AN/A-5,529.96%-248.88%-744.99%-349.74%-35.97%16.35%43.85%56.87%53.97%
EPS
YoY % growth
XFOR eps by date.XFOR eps by date.
-56.10
49.46%
-18.00
67.91%
-21.30
-18.33%
-2.79
86.91%
-1.10
60.49%
-1.05
4.63%
-0.38
63.59%
0.53
238.67%
1.74
227.88%
0.87
-50.15%
2.67
208.24%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.39
93.54%
-0.24
-703.51%
-0.24
93.14%
-0.24
65.51%
-0.24
38.60%
Revenue
Q2Q % growth
1.768M
23.29%
3.978M
-86.19%
2.618M
32.69%
2.72M
54.11%
2.958M
67.31%
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-24.676M
30.91%
-23.111M
-144.74%
-22.733M
13.34%
-22.369M
18.69%
-21.864M
11.40%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.69
87.22%
-0.930.2426.15%
Q2 2025
Q2Q % growth
-3.47
-65.24%
-4.420.9521.58%
Q1 2025
Q2Q % growth
0.04
100.51%
-4.534.57100.88%
Q4 2024
Q2Q % growth
-6.00
-100.00%
-5.36-0.64-12.04%
Q3 2024
Q2Q % growth
-5.40
-1,700.00%
-5.29-0.11-2.09%
Q2 2024
Q2Q % growth
-2.10
78.79%
0.17-2.27-1,301.88%
Q1 2024
Q2Q % growth
-7.80
-62.50%
-4.98-2.82-56.52%
Q4 2023
Q2Q % growth
-3.00
65.52%
-4.681.6835.86%
Q3 2023
Q2Q % growth
-0.30
96.15%
-4.564.2693.42%
Q2 2023
Q2Q % growth
-9.90
45.00%
-5.00-4.90-98.08%
Q1 2023
Q2Q % growth
-4.80
77.78%
-6.641.8427.76%
Q4 2022
Q2Q % growth
-8.70
67.78%
-7.38-1.32-17.85%
Q3 2022
Q2Q % growth
-7.80
65.79%
-9.161.3614.81%
Q2 2022
Q2Q % growth
-18.00
18.92%
-19.541.547.88%
Q1 2022
Q2Q % growth
-21.60
44.62%
-18.62-2.98-15.99%
Q4 2021
Q2Q % growth
-27.00
1.10%
-20.90-6.10-29.21%
Q3 2021
Q2Q % growth
-22.80
-2.70%
-22.11-0.69-3.13%
Q2 2021
Q2Q % growth
-22.20
2.63%
-22.610.411.79%
Q1 2021
Q2Q % growth
-39.00
-132.14%
-26.28-12.72-48.42%
Q4 2020
Q2Q % growth
-27.30
-37.88%
-27.630.331.20%
Q3 2020
Q2Q % growth
-22.20
21.28%
-23.120.923.99%
Q2 2020
Q2Q % growth
-22.80
25.49%
-21.95-0.85-3.88%
Q1 2020
Q2Q % growth
-16.80 -24.407.6031.15%
Q4 2019
Q2Q % growth
-19.80 -25.445.6422.18%
Q3 2019
Q2Q % growth
-28.20 -32.714.5113.79%
Q2 2019
Q2Q % growth
-30.60 -29.28-1.32-4.52%
XFOR Yearly EPS VS EstimatesXFOR Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -500 -1K -1.5K -2K
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
1.765M
215.18%
2.083M-318K-15.27%
Q2 2025
Q2Q % growth
1.973M
250.44%
1.644M329K20.01%
Q1 2025
Q2Q % growth
28.807M 2.038M26.769M1,313.49%
Q4 2024
Q2Q % growth
1.434M 1.062M372K35.03%
Q3 2024
Q2Q % growth
560K 1.727M-1.167M-67.57%
Q2 2024
Q2Q % growth
563K 284.243K278.757K98.07%
Q1 2022
Q2Q % growth
123.859K-123.859K-100.00%
Q1 2021
Q2Q % growth

-100.00%
%
XFOR Yearly Revenue VS EstimatesXFOR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2020 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS20% 39.68% 25.97% 25.97%
Revenue-30.34% -32.05% -2.19% -2.19%